Worldwide association of the gender inequality with the incidence and mortality of cervical, ovarian, endometrial, and breast cancers

被引:1
|
作者
Kavousi, Shahin [1 ]
Maharlouei, Najmeh [2 ]
Rezvani, Alireza [3 ]
Aliabad, Hossein Akbari [4 ]
Vardanjani, Hossein Molavi [5 ]
机构
[1] Shiraz Univ Med Sci, Sch Med, MD MPH Dept, Shiraz, Iran
[2] Shiraz Univ Med Sci, Inst Hlth, Hlth Policy Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Stem Cells Res Inst, Hematol Res Ctr, Sch Med,Dept Internal Med, Shiraz, Iran
[4] Shiraz Univ Med Sci & Hlth Serv, Sch Med, Student Res Comm, Shiraz, Iran
[5] Shiraz Univ Med Sci, Res Ctr Tradit Med & Hist Med, Sch Med, MD MPH Dept, Shiraz, Iran
关键词
Gender inequality; Gender development; Gynecologic neoplasms; Cancer incidence; Cancer mortality; Breast cancer; Cervical cancer; HUMAN-DEVELOPMENT INDEX; GLOBAL CANCER; HEALTH; COUNTRIES; DISPARITIES; EQUALITY; BURDEN;
D O I
10.1016/j.ssmph.2024.101613
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: There is a huge disparity in cancer incidence and mortality around the globe. A considerable share of this disparity can be explained by human development. Particularly in many less developed countries, women have been hindered in their human development. In this ecological study, we hypothesize that, notwithstanding acceptable overall development in countries, gender inequalities might affect the incidence and mortality of women's malignancies, and there is a distinct association between them. Method: The data on the incidence and mortality of gynecologic and female breast cancers were retrieved from the GLOBOCAN database, and the data on the Human Development Index (HDI), Gender Development Index (GDI), and Gender Inequality Index (GII) were obtained from the United Nations Human Development Report. The Poisson regression modeling was then used to fit four models for each cancer. Result: GII and GDI are both significantly associated with incidences of women's cancers, except for the insignificant association between GDI and the incidence of ovarian cancer. However, the association between GDI and the mortality of women's cancer is not strong. At the same time, there are significant direct relationships between GII and the mortality of breast, cervical, and endometrial cancer. Conclusion: The incidence and mortality of women's cancers are ecologically associated with the country-level gender inequality captured with GDI and GII.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Toremifene and breast cancer therapy: incidence of secondary endometrial cancers.
    Erkkola, R
    Nevala, P
    Mantyla, E
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156
  • [42] Endometrial and cervical cancer: incidence and mortality among women in the Lodz region
    Lesniczak, Beata
    Krasomski, Grzegorz
    Oszukowski, Przemyslaw
    Stetkiewicz, Tomasz
    Wozniak, Piotr
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2015, 14 (03): : 192 - 195
  • [43] Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years
    Lin, Shujuan
    Gao, Kai
    Gu, Simeng
    You, Liuqing
    Qian, Sangni
    Tang, Mengling
    Wang, Jianbing
    Chen, Kun
    Jin, Mingjuan
    CANCER, 2021, 127 (21) : 4030 - 4039
  • [44] Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015
    Lim, Myong Cheol
    Won, Young-Joo
    Ko, Mun Jung
    Kim, Miseon
    Shim, Seung-Hyuk
    Suh, Dong Hoon
    Kim, Jae-Weon
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (01)
  • [45] Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility
    Gregga, Isabelle
    Pharoah, Paul D. P.
    Gayther, Simon A.
    Manichaikul, Ani
    Im, Hae Kyung
    Kar, Siddhartha P.
    Schildkraut, Joellen M.
    Wheeler, Heather E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (09) : 1198 - 1207
  • [46] New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review
    Gheorghe, Adelina Silvana
    Dumitrescu, Elena Adriana
    Komporaly, Isabela Anda
    Mihaila, Raluca Ioana
    Lungulescu, Cristian Virgil
    Stanculeanu, Dana Lucia
    CURRENT ONCOLOGY, 2022, 29 (04) : 2835 - 2847
  • [47] Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers: The Cooper Center Longitudinal Study
    Peel, Amanda B.
    Barlow, Carolyn E.
    Leonard, David
    DeFina, Laura F.
    Jones, Lee W.
    Lakoski, Susan G.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 394 - 397
  • [48] Breast, Ovarian and Endometrial Cancers in Women Diagnosed with SLE before Age 40
    Tissera, Hiromi
    Clarke, Ann
    Ramsey-Goldman, Rosalind
    Ginzler, Ellen
    Urowitz, Murray
    Gladman, Dafna
    Fortin, Paul
    Petri, Michelle
    Hanly, John
    Peschken, Christine
    Edworthy, Steven
    Barr, Susan
    Gordon, Caroline
    Bae, Sang-Cheol
    Isenberg, David
    Rahman, Anisur
    Aranow, Cynthia
    Dooley, Mary
    Nived, Ola
    Senecal, Jean-Luc
    Zummer, Michel
    Ensworth, Stephanie
    Pope, Janet
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1269 - 1269
  • [49] Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: Prospective studies
    Eliassen, A. Heather
    Hankinson, Susan E.
    INNOVATIVE ENDOCRINOLOGY OF CANCER, 2008, 630 : 148 - 165
  • [50] A Prospective Study on Dietary Acrylamide Intake and the Risk for Breast, Endometrial, and Ovarian Cancers
    Wilson, Kathryn M.
    Mucci, Lorelei A.
    Rosner, Bernard A.
    Willett, Walter C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (10) : 2503 - 2515